Clinical Trials Directory

Trials / Unknown

UnknownNCT05620589

The Effect of Time Intervals for Rescue Treatment on Eradication Effect of Helicobacter Pylori Infection

The Effect of Different Time Intervals on Rescue Treatment of Helicobacter Pylori Infection: a Prospective, Multicenter Observational Study

Status
Unknown
Phase
Study type
Observational
Enrollment
626 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The researchers collect patients who accepted eradication program of the helicobacter pylori but failed to eradicate helicobacter pylor from the outpatient clinic. After rescue therapy, evaluating the effect of retreatment interval on eradication effect of Helicobacter pylori infection.

Detailed description

The researchers collect patients who accepted eradication program of the helicobacter pylori but failed to eradicate helicobacter pylor from the outpatient clinic. Record the interval between the last eradication therapy and this time,6-8 weeks after treatment, the subjects will re-take the 13C-urea breath test. Calculating the eradication rates, adverse reaction rates, patient compliance of each group. Evaluating the effect of retreatment interval on eradication effect of Helicobacter pylori infection.

Conditions

Interventions

TypeNameDescription
DRUGAmoxicillin + Tetracycline + Bismuth + EsomeprazoleAmoxicillin 1000mg bid+ Tetracycline 500mg qid+ Bismuth + Esomeprazole 40mg bid or Amoxicillin 1000mg bid+ Tetracycline 500mg tid+ Bismuth + Esomeprazole 40mg bid
DRUGAmoxicillin + Tetracycline + Bismuth + VonoprazanAmoxicillin 1000mg bid+ Tetracycline 500mg qid+ Bismuth +Vonoprazan 20mg bid or Amoxicillin1000mg bid+ Tetracycline 500mg tid+ Bismuth + Vonoprazan 20mg bid
DRUGAmoxicillin + Tetracycline + Bismuth + TegoprazanAmoxicillin 1000mg bid+ Tetracycline 500mg qid+ Bismuth + Tegoprazan 50mg bid or Amoxicillin 1000mg bid+ Tetracycline 500mg tid+ Bismuth + Tegopraza 50mg bid

Timeline

Start date
2022-11-11
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2022-11-17
Last updated
2022-11-17

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05620589. Inclusion in this directory is not an endorsement.